Results 31 to 40 of about 59,389 (246)

A Caspase-Resistant Form of Bcl-XL, but Not Wild Type Bcl-XL, Promotes Clonogenic Survival After Ionizing Radiation

open access: yesNeoplasia: An International Journal for Oncology Research, 1999
Bcl-2 and Bcl-XL belong to a family of proteins overexpressed in a variety of human cancers which inhibit apoptosis in response to a number of stimuli including chemotherapeutic agents and ionizing radiation.
Alnawaz Rehemtulla   +6 more
doaj   +1 more source

Restoring Bcl-xL levels benefits a mouse model of spinal muscular atrophy

open access: yesNeurobiology of Disease, 2008
Currently, no curative treatment is available for spinal muscular atrophy (SMA). Since the degeneration of spinal motor neurons in SMA is mediated by apoptosis, over-expression of an anti-apoptotic factor, Bcl-xL, may benefit SMA.
Li-Kai Tsai   +4 more
doaj   +1 more source

SENP3 Promotes an Mff-Primed Bcl-xL-Drp1 Interaction Involved in Cell Death Following Ischemia

open access: yesFrontiers in Cell and Developmental Biology, 2021
Dysregulation of the mitochondrial fission machinery has been linked to cell death following ischemia. Fission is largely dependent on recruitment of Dynamin-related protein 1 (Drp1) to the receptor Mitochondrial fission factor (Mff) located on the ...
Chun Guo   +7 more
doaj   +1 more source

Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and ApoptosisSummary

open access: yesCellular and Molecular Gastroenterology and Hepatology, 2017
Background & Aims: Bcl-xL, an anti-apoptotic Bcl-2 family protein, is overexpressed in 90% of pancreatic ductal adenocarcinoma (PDAC) cases. However, Bcl-xL expression in pancreatic intraepithelial neoplasias (PanINs) and its significance in PDAC ...
Kenji Ikezawa   +7 more
doaj   +1 more source

Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,

open access: yesNature Communications, 2021
Simultaneous targeting of BCL-xL and BCL-2 is an attractive approach for cancer treatment. Based on information gained by computational structure modelling, the authors develop a PROTAC that induces degradation of both BCL-xL and BCL-2 and effectively ...
Dongwen Lv   +23 more
doaj   +1 more source

Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma [PDF]

open access: yesBritish Journal of Cancer, 2013
Bcl-xL has an important role in the control of cell death through its inhibition of apoptosis. The aim of this study was to investigate the clinicopathological significance of Bcl-xL in upper urinary tract urothelial carcinoma (UTUC) and the therapeutic effect of targeting Bcl-xL protein in urothelial carcinoma (UC) cells.We evaluated the ...
Yoshimine, S   +6 more
openaire   +2 more sources

Bcl-xL Is Spontaneously Inserted into Preassembled Nanodiscs and Stimulates Bax Insertion in a Cell-Free Protein Synthesis System

open access: yesBiomolecules, 2023
The antiapoptotic protein Bcl-xL is a major regulator of cell death and survival, but many aspects of its functions remain elusive. It is mostly localized in the mitochondrial outer membrane (MOM) owing to its C-terminal hydrophobic α-helix.
Akandé Rouchidane Eyitayo   +4 more
doaj   +1 more source

Deamidation of Bcl-XL [PDF]

open access: yesMolecular Cell, 2002
Bcl-2 proteins are critical regulators of apoptosis following DNA damage. Recent studies have shown that genotoxic stress induces the deamidation of Bcl-X(L), inhibiting its antiapoptotic activities. Remarkably, Rb and p53 are important regulators of this novel modification of Bcl-X(L).
openaire   +1 more source

Regulation of Bcl-xl Channel Activity by Calcium [PDF]

open access: hybridJournal of Biological Chemistry, 1998
Recent studies have demonstrated that the anti-apoptotic proteins, Bcl-2 and Bcl-xl, with the carboxyl-terminal hydrophobic domain removed, form cation-selective channels in the lipid bilayer reconstitution system. However, the regulatory properties of these channels are unknown.
Minh Lam   +4 more
openalex   +4 more sources

De novo pyrimidine biosynthesis inhibition synergizes with BCL-X<sub>L</sub> targeting in pancreatic cancer. [PDF]

open access: goldNat Commun
Zhang H   +16 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy